Key result
Aneurysmal SAH linked to ~8-fold higher in-hospital mortality than diffuse angiogram-negative SAH.
Why the study?
The clinical outcome of diffuse angiogram-negative subarachnoid hemorrhage compared with aneurysmal subarachnoid hemorrhage remained unclear.
Does diffuse angiogram-negative subarachnoid hemorrhage have different clinical complications and 3-month functional outcomes compared with aneurysmal subarachnoid hemorrhage in patients with spontaneous subarachnoid hemorrhage?
Cohort (n=922)
No
Does diffuse angiogram-negative subarachnoid hemorrhage have different clinical complications and 3-month functional outcomes compared with aneurysmal subarachnoid hemorrhage in patients with spontaneous subarachnoid hemorrhage?
Patients with aneurysmal subarachnoid hemorrhage have significantly higher rates of in-hospital rehemorrhage, delayed cerebral ischemia, and mortality than propensity-matched patients with diffuse angiogram-negative subarachnoid hemorrhage, though 3-month functional outcomes do not significantly differ by hemorrhage pathogenesis.
Answers are grounded in this paper and cite their sources.
Aneurysmal SAH may warrant closer complication surveillance than angiogram-negative cases; observational data leaves open causal mechanisms and practice change.
Background The outcome of diffuse angiogram‐negative subarachnoid hemorrhage (dan‐SAH) compared with aneurysmal SAH (aSAH) remains unclear. This study aimed to compare outcomes using propensity score matching. Methods and Results Sixty‐five patients with dan‐SAH and 857 patients with aSAH admitted between January 2018 and December 2022 were retrospectively reviewed. Propensity score matching resulted in matching 65 patients with dan‐SAH to 260 patients with aSAH, and clinical outcomes were compared between the groups. Compared with patients with dan‐SAH, patients with aSAH were more likely to experience rehemorrhage (8.8% versus 0%, P =0.027), death (11.2% versus 1.5%; odds ratios [OR] 8.04 [95% CI, 1.07–60.12]; P =0.042), or delayed cerebral ischemia (12.3% versus 3.1%; OR, 4.42 [95% CI, 1.03–18.95]; P =0.045). Multivariate analysis revealed that Hunt–Hess grade 4 to 5 (OR, 3.13 [95% CI, 2.11–4.64]; P <0.001), presence of intraventricular hemorrhage (OR, 3.58 [95% CI, 1.72–7.46]; P =0.001), and smoking (OR, 2.44 [95% CI, 1.12–5.28]; P =0.024) were independently associated with the incidence of unfavorable outcomes (modified Rankin scale score >2 at 3 months), whereas dan‐SAH was not (OR, 0.66 [95% CI, 0.25–1.73]; P =0.40). Conclusions Compared with patients with dan‐SAH, patients with aSAH had higher rehemorrhage rates and in‐hospital mortality, as well as a higher incidence of delayed cerebral ischemia. Unfavorable outcomes were associated with admission Hunt–Hess grade, the presence of intravenetricular hemorrhage, and smoking history, but there was no relation with the pathogenesis of the hemorrhage (dan‐SAH versus aSAH).
No takes yet. Share an insight, caveat, or question.
Lu et al. (2023) conducted a cohort in Spontaneous subarachnoid hemorrhage (diffuse angiogram-negative SAH vs aneurysmal SAH) (n=922). Aneurysmal subarachnoid hemorrhage (aSAH) vs. Diffuse angiogram-negative subarachnoid hemorrhage (dan-SAH) was evaluated on In-hospital mortality (OR 8.04, 95% CI 1.07-60.12, p=0.042). Aneurysmal SAH was associated with higher in-hospital mortality (11.2% vs 1.5%, OR 8.04, p=0.042) and delayed cerebral ischemia (12.3% vs 3.1%, p=0.045) compared to diffuse angiogram-negative SAH.
Synapse has enriched 10 related papers. Consider them for comparative context: